Wagner, L. M., Perentesis, J. P., Reid, J. M., Ames, M. M., Safgren, S. L., Nelson, M. D., . . . Adamson, P. C. (2010). Phase I Trial of Two Schedules of Vincristine, Oral Irinotecan, and Temozolomide (VOIT) for Children with Relapsed or Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Study.

Wagner, Lars M., John P. Perentesis, Joel M. Reid, Matthew M. Ames, Stephanie L. Safgren, Marvin D. Nelson, Ashish M. Ingle, Susan M. Blaney, and Peter C. Adamson. Phase I Trial of Two Schedules of Vincristine, Oral Irinotecan, and Temozolomide (VOIT) for Children With Relapsed or Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Study. 2010.

Wagner, Lars M., et al. Phase I Trial of Two Schedules of Vincristine, Oral Irinotecan, and Temozolomide (VOIT) for Children With Relapsed or Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Study. 2010.